VenaSeal

VenaSeal maintains safety and efficacy at extended five-year follow-up

The first-ever 60-month data on Medtronic’s VenaSeal closure system were presented on Tuesday, indicating that at five years, treatment with the cyanoacrylate adhesive for...
paclitaxel

While CX audience deems paclitaxel not dangerous, vascular pathologist says establishing “truth takes time”

Delegates voted overwhelmingly against the notion that there was a demonstrable danger in any organ of the body attributed to circulating paclitaxel. These polling...

EVAR funding threatened, while strategy for safe, cost-effective repair is “just around the corner”

The durability of endovascular aneurysm repair (EVAR) is in the limelight as the UK vascular community awaits the final aortic aneurysm guidelines from the...

Positive outcomes of Eluvia drug-eluting stent in IMPERIAL sub-analyses

Boston Scientific has announced results from sub-analyses of the IMPERIAL clinical trial for the Eluvia Drug-Eluting Vascular Stent System at the 41st Charing Cross...

Alberto Muñoz

Gustavo Oderich

Alison Halliday

(Visited 32,436 times, 6 visits today)